Inova Health System:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Inova Health System - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5147
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inova Health System (Inova) is a non-profit health care system operating through multiple hospitals. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of hospitals including Inova Alexandria Hospital, Inova Fair Oaks Hospital, Inova Fairfax Hospital, Inova Loudoun Hospital, and Inova Mount Vernon Hospital the organization provides inpatient services and outpatient health services including emergency and urgent care, senior services, home care, mental health and blood donor services. Its other healthcare facilities include Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) which focuses on genomics research, Inova Neuroscience Institute and Inova Children’s Hospital. Inova is headquartered in Falls Church, Virginia, the US.

Inova Health System – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inova Health System, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Inova Health System Enters into Research Agreement with George Mason University 11
Debt Offering 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For US$1.7 Million 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For US$85.1 Million 13
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For US$3.3 Million 14
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For US$3.4 Million 15
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For US$1.9 Million 16
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For US$35 Million 17
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For US$4.1 Million 18
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For US$2.6 Million 19
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$2 Million 20
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For US$3.3 Million 21
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For US$4.4 Million 22
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$33 Million 23
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For US$2.9 Million 24
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For US$4.3 Million 25
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For US$4.5 Million 26
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For US$2.7 Million 27
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$25 Million 28
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For US$5.2 Million 29
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For US$3.4 Million 30
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For US$3.3 Million 31
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For US$4 Million 32
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For US$15 Million 33
Acquisition 34
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34
Inova Health System – Key Competitors 35
Inova Health System – Key Employees 36
Inova Health System – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 39
Corporate Communications 39
Mar 14, 2018: Inova Board Names J. Stephen Jones as New Chief Executive Officer 39
Oct 18, 2017: The Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors 40
Sep 15, 2017: Inova CEO Knox Singleton Announces Retirement 41
Sep 06, 2017: Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization 42
Government and Public Interest 43
May 18, 2018: President George W. Bush Headlines Record-Breaking Fundraiser for Inova Schar Cancer Institute 43
Other Significant Developments 44
Feb 23, 2018: Inova Loudoun Hospital Mobile Health Services March 2018 Screenings Schedule 44
Feb 19, 2018: Inova Loudoun Hospital Offering New Hope And Insights 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Inova Health System, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inova Health System Enters into Research Agreement with George Mason University 11
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For US$1.7 Million 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For US$85.1 Million 13
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For US$3.3 Million 14
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For US$3.4 Million 15
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For US$1.9 Million 16
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For US$35 Million 17
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For US$4.1 Million 18
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For US$2.6 Million 19
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$2 Million 20
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For US$3.3 Million 21
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For US$4.4 Million 22
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$33 Million 23
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For US$2.9 Million 24
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For US$4.3 Million 25
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For US$4.5 Million 26
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For US$2.7 Million 27
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$25 Million 28
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For US$5.2 Million 29
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For US$3.4 Million 30
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For US$3.3 Million 31
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For US$4 Million 32
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For US$15 Million 33
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34
Inova Health System, Key Competitors 35
Inova Health System, Key Employees 36
Inova Health System, Other Locations 37
Inova Health System, Subsidiaries 38

List of Figures
Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Inova Health System:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Catholic University of Leuven:医療機器:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • EIH Limited:戦略・SWOT・企業財務分析
    EIH Limited - Strategy, SWOT and Corporate Finance Report Summary EIH Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Athera Biotechnologies AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Athera Biotechnologies AB (Athera) is a clinical stage biopharmaceutical company that focuses on the development of anti-inflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The company develops a proprietary clinical development stage program, …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Triodos Bank NV:企業の戦略・SWOT・財務情報
    Triodos Bank NV - Strategy, SWOT and Corporate Finance Report Summary Triodos Bank NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CEWE Stiftung & Co.KGaA (CWC):企業の財務・戦略的SWOT分析
    CEWE Stiftung & Co.KGaA (CWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Wellcome Trust:企業の戦略的SWOT分析
    Wellcome Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Aviragen Therapeutics Inc (AVIR)-医療機器分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Enerkem Inc:企業の戦略的SWOT分析
    Enerkem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TiVo Corp.:企業の戦略・SWOT・財務情報
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Adient Plc (ADNT):企業の財務・戦略的SWOT分析
    Adient Plc (ADNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GenomeDx Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Birchcliff Energy Ltd (BIR):石油・ガス:M&Aディール及び事業提携情報
    Summary Birchcliff Energy Ltd. (Birchcliff) is an intermediate oil and gas company that explores for, develops and produces natural gas, light oil and natural gas liquids. Its product portfolio includes crude oil, natural gas, natural gas liquids, and light and medium oils. The company operates in t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆